{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:49:46Z","timestamp":1791946186080,"version":"4.3.4"},"reference-count":224,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901088"],"award-info":[{"award-number":["81901088"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["E2019050019"],"award-info":[{"award-number":["E2019050019"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["H2022206562"],"award-info":[{"award-number":["H2022206562"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["H2022206511"],"award-info":[{"award-number":["H2022206511"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NV20230011"],"award-info":[{"award-number":["NV20230011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hundred Talents Program of Hebei Province","award":["81901088"],"award-info":[{"award-number":["81901088"]}]},{"name":"Hundred Talents Program of Hebei Province","award":["E2019050019"],"award-info":[{"award-number":["E2019050019"]}]},{"name":"Hundred Talents Program of Hebei Province","award":["H2022206562"],"award-info":[{"award-number":["H2022206562"]}]},{"name":"Hundred Talents Program of Hebei Province","award":["H2022206511"],"award-info":[{"award-number":["H2022206511"]}]},{"name":"Hundred Talents Program of Hebei Province","award":["NV20230011"],"award-info":[{"award-number":["NV20230011"]}]},{"name":"Hebei Provincial Natural Science Foundation\u2019s Precision Medicine Joint Fund\u2019s Cultivation Project","award":["81901088"],"award-info":[{"award-number":["81901088"]}]},{"name":"Hebei Provincial Natural Science Foundation\u2019s Precision Medicine Joint Fund\u2019s Cultivation Project","award":["E2019050019"],"award-info":[{"award-number":["E2019050019"]}]},{"name":"Hebei Provincial Natural Science Foundation\u2019s Precision Medicine Joint Fund\u2019s Cultivation Project","award":["H2022206562"],"award-info":[{"award-number":["H2022206562"]}]},{"name":"Hebei Provincial Natural Science Foundation\u2019s Precision Medicine Joint Fund\u2019s Cultivation Project","award":["H2022206511"],"award-info":[{"award-number":["H2022206511"]}]},{"name":"Hebei Provincial Natural Science Foundation\u2019s Precision Medicine Joint Fund\u2019s Cultivation Project","award":["NV20230011"],"award-info":[{"award-number":["NV20230011"]}]},{"name":"Key Laboratory of Neural and Vascular Biology of the Ministry of Education of China","award":["81901088"],"award-info":[{"award-number":["81901088"]}]},{"name":"Key Laboratory of Neural and Vascular Biology of the Ministry of Education of China","award":["E2019050019"],"award-info":[{"award-number":["E2019050019"]}]},{"name":"Key Laboratory of Neural and Vascular Biology of the Ministry of Education of China","award":["H2022206562"],"award-info":[{"award-number":["H2022206562"]}]},{"name":"Key Laboratory of Neural and Vascular Biology of the Ministry of Education of China","award":["H2022206511"],"award-info":[{"award-number":["H2022206511"]}]},{"name":"Key Laboratory of Neural and Vascular Biology of the Ministry of Education of China","award":["NV20230011"],"award-info":[{"award-number":["NV20230011"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Over the past two decades, significant advancements have been made in the induced pluripotent stem cell (iPSC) technology. These developments have enabled the broader application of iPSCs in neuroscience, improved our understanding of disease pathogenesis, and advanced the investigation of therapeutic targets and methods. Specifically, optimizations in reprogramming protocols, coupled with improved neuronal differentiation and maturation techniques, have greatly facilitated the generation of iPSC-derived neural cells. The integration of the cerebral organoid technology and CRISPR\/Cas9 genome editing has further propelled the application of iPSCs in neurodegenerative diseases to a new stage. Patient-derived or CRISPR-edited cerebral neurons and organoids now serve as ideal disease models, contributing to our understanding of disease pathophysiology and identifying novel therapeutic targets and candidates. In this review, we examine the development of iPSC-based models in neurodegenerative diseases, including Alzheimer\u2019s disease, Parkinson\u2019s disease, and Huntington\u2019s disease.<\/jats:p>","DOI":"10.3390\/ijms26083774","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T11:02:57Z","timestamp":1744801377000},"page":"3774","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Current Development of iPSC-Based Modeling in Neurodegenerative Diseases"],"prefix":"10.3390","volume":"26","author":[{"given":"Xiangge","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Human Anatomy, Hebei Medical University, Shijiazhuang 050017, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xumeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy, Hebei Medical University, Shijiazhuang 050017, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy, Hebei Medical University, Shijiazhuang 050017, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy, Hebei Medical University, Shijiazhuang 050017, China"},{"name":"Human Brain Bank, Hebei Medical University, Shijiazhuang 050017, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy, Hebei Medical University, Shijiazhuang 050017, China"},{"name":"The Key Laboratory of Neural and Vascular Biology, Ministry of Education, Hebei Medical University, Shijiazhuang 050017, China"},{"name":"Hebei Key Laboratory of Neurodegenerative Disease Mechanism, Hebei Medical University, Shijiazhuang 050017, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1161\/CIRCRESAHA.117.311080","article-title":"Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications","volume":"120","author":"Yoshida","year":"2017","journal-title":"Circ. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1152\/physrev.00039.2017","article-title":"Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development","volume":"99","author":"Karagiannis","year":"2019","journal-title":"Physiol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/nrg3563","article-title":"Pluripotent stem cells in regenerative medicine: Challenges and recent progress","volume":"15","author":"Tabar","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mcn.2015.11.010","article-title":"Modeling Alzheimer\u2019s Disease with Human Induced Pluripotent Stem (iPS) Cells","volume":"73","author":"Mungenast","year":"2016","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Chang, C.Y., Ting, H.C., Liu, C.A., Su, H.L., Chiou, T.W., Lin, S.Z., Harn, H.J., and Ho, T.J. (2020). Induced Pluripotent Stem Cell (iPSC)-Based Neurodegenerative Disease Models for Phenotype Recapitulation and Drug Screening. Molecules, 25.","DOI":"10.3390\/molecules25082000"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Akter, M., and Ding, B. (2022). Modeling Movement Disorders via Generation of hiPSC-Derived Motor Neurons. Cells, 11.","DOI":"10.3390\/cells11233796"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"135028","DOI":"10.1016\/j.neulet.2020.135028","article-title":"Characterization of human iPSC-derived astrocytes with potential for disease modeling and drug discovery","volume":"731","author":"Soubannier","year":"2020","journal-title":"Neurosci. Lett."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.stem.2020.09.014","article-title":"Pluripotent stem cell-based cell therapy-Promise and challenges","volume":"27","author":"Yamanaka","year":"2020","journal-title":"Cell Stem Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neuron.2019.07.014","article-title":"CRISPR Interference-Based Platform for Multimodal Genetic Screens in Human iPSC-Derived Neurons","volume":"104","author":"Tian","year":"2019","journal-title":"Neuron"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.stem.2020.10.014","article-title":"CRISPR-Cas Tools and Their Application in Genetic Engineering of Human Stem Cells and Organoids","volume":"27","author":"Hendriks","year":"2020","journal-title":"Cell Stem Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.gene.2018.11.069","article-title":"An insight into non-integrative gene delivery approaches to generate transgene-free induced pluripotent stem cells","volume":"686","author":"Haridhasapavalan","year":"2019","journal-title":"Gene"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature05934","article-title":"Generation of germline-competent induced pluripotent stem cells","volume":"448","author":"Okita","year":"2007","journal-title":"Nature"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-1-62703-348-0_3","article-title":"A review of the methods for human iPSC derivation","volume":"997","author":"Malik","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nature07863","article-title":"PiggyBac transposition reprograms fibroblasts to induced pluripotent stem cells","volume":"458","author":"Woltjen","year":"2009","journal-title":"Nature"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Kawaguchi, T., Tsukiyama, T., Kimura, K., Matsuyama, S., Minami, N., Yamada, M., and Imai, H. (2015). Generation of Na\u00efve Bovine Induced Pluripotent Stem Cells Using PiggyBac Transposition of Doxycycline- Inducible Transcription Factors. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0135403"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nmeth.1426","article-title":"A nonviral minicircle vector for deriving human iPS cells","volume":"7","author":"Jia","year":"2010","journal-title":"Nat. Methods"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.1172482","article-title":"Human induced pluripotent stem cells free of vector and transgene sequences","volume":"324","author":"Yu","year":"2009","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1164270","article-title":"Generation of mouse induced pluripotent stem cells without viral vectors","volume":"322","author":"Okita","year":"2008","journal-title":"Science"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.stem.2010.08.012","article-title":"Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA","volume":"7","author":"Warren","year":"2010","journal-title":"Cell Stem Cell"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nbt.1862","article-title":"Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells","volume":"29","author":"Subramanyam","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.stem.2011.03.001","article-title":"Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency","volume":"8","author":"Trivedi","year":"2011","journal-title":"Cell Stem Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nbt1374","article-title":"Generation of induced pluripotent stem cells without Myc frome mouse and human fibroblasts","volume":"26","author":"Nakagawa","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-2443.2009.01301.x","article-title":"Roles of Sall4 in the generation of pluripotent stem cells from blastocysts and fibroblasts","volume":"14","author":"Tsubooka","year":"2009","journal-title":"Genes Cells"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nature10106","article-title":"Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1","volume":"474","author":"Maekawa","year":"2011","journal-title":"Nature"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.stem.2009.12.009","article-title":"The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells","volume":"6","author":"Heng","year":"2010","journal-title":"Cell Stem Cell"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Yu, J., Chau, K.F., Vodyanik, M.A., Jiang, J., and Jiang, Y. (2011). Efficient feeder-free episomal reprogramming with small molecules. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0017557"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.stemcr.2016.04.001","article-title":"Optimized Approaches for Generation of Integration-free iPSCs from Human Urine-Derived Cells with Small Molecules and Autologous Feeder","volume":"6","author":"Li","year":"2016","journal-title":"Stem Cell Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12015-019-09935-x","article-title":"Advances in Pluripotent Stem Cells: History, Mechanisms, Technologies, and Applications","volume":"16","author":"Liu","year":"2020","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nature09805","article-title":"Somatic coding mutations in human induced pluripotent stem cells","volume":"471","author":"Gore","year":"2011","journal-title":"Nature"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.cell.2010.07.039","article-title":"Generation of rat pancreas in mouse by interspecific blastocyst injection of pluripotent stem cells","volume":"142","author":"Kobayashi","year":"2010","journal-title":"Cell"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Neira, J.A., Conrad, J.V., Rusteika, M., and Chu, L.F. (2024). The progress of induced pluripotent stem cells derived from pigs: A mini review of recent advances. Front. Cell Dev. Biol., 12.","DOI":"10.3389\/fcell.2024.1371240"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/scrt171","article-title":"Large animal models for stem cell therapy","volume":"4","author":"Harding","year":"2013","journal-title":"Stem Cell Res. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"31362","DOI":"10.1074\/jbc.M110.150540","article-title":"Generation of induced pluripotent stem cells in rabbits: Potential experimental models for human regenerative medicine","volume":"285","author":"Honda","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.stem.2008.10.014","article-title":"Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts","volume":"3","author":"Liu","year":"2008","journal-title":"Cell Stem Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s12015-011-9239-5","article-title":"Induced pluripotent stem cell lines derived from equine fibroblasts","volume":"7","author":"Nagy","year":"2011","journal-title":"Stem Cell Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"768391","DOI":"10.1155\/2014\/768391","article-title":"A Comparative View on Human Somatic Cell Sources for iPSC Generation","volume":"2014","author":"Raab","year":"2014","journal-title":"Stem Cells Int."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1007\/s12015-021-10200-3","article-title":"An Overview on Promising Somatic Cell Sources Utilized for the Efficient Generation of Induced Pluripotent Stem Cells","volume":"17","author":"Ray","year":"2021","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41392-024-01809-0","article-title":"Induced pluripotent stem cells (iPSCs): Molecular mechanisms of induction and applications","volume":"9","author":"Cerneckis","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.stem.2010.06.002","article-title":"Reprogramming of human peripheral blood cells to induced pluripotent stem cells","volume":"7","author":"Staerk","year":"2010","journal-title":"Cell Stem Cell"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.stem.2010.06.004","article-title":"Reprogramming of T cells from human peripheral blood","volume":"7","author":"Loh","year":"2010","journal-title":"Cell Stem Cell"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5476","DOI":"10.1182\/blood-2009-02-204800","article-title":"Generation of induced pluripotent stem cells from human blood","volume":"113","author":"Loh","year":"2009","journal-title":"Blood"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1182\/blood-2009-04-217406","article-title":"Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders","volume":"114","author":"Ye","year":"2009","journal-title":"Blood"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1182\/blood-2012-03-420273","article-title":"Transgene-free iPSCs generated from small volume peripheral blood nonmobilized CD34+ cells","volume":"121","author":"Merling","year":"2013","journal-title":"Blood"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Mack, A.A., Kroboth, S., Rajesh, D., and Wang, W.B. (2011). Generation of Induced Pluripotent Stem Cells from CD34+ Cells across Blood Drawn from Multiple Donors with Non-Integrating Episomal Vectors. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0027956"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1089\/cell.2020.0040","article-title":"Going Back and Forth: Episomal Vector Reprogramming of Peripheral Blood Mononuclear Cells to Induced Pluripotent Stem Cells and Subsequent Differentiation into Cardiomyocytes and Neuron-Astrocyte Co-cultures","volume":"22","author":"Imholz","year":"2020","journal-title":"Cell. Reprogramming"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s12015-019-09900-8","article-title":"Reprogramming of Keratinocytes as Donor or Target Cells Holds Great Promise for Cell Therapy and Regenerative Medicine","volume":"15","author":"Zhang","year":"2019","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"15720","DOI":"10.1073\/pnas.0908450106","article-title":"Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells","volume":"106","author":"Sun","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1681\/ASN.2011010106","article-title":"Generation of Induced Pluripotent Stem Cells from Urine","volume":"22","author":"Zhou","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1634\/stemcells.2008-0317","article-title":"Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression","volume":"26","author":"Eminli","year":"2008","journal-title":"Stem Cells"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1126\/science.1154884","article-title":"Generation of pluripotent stem cells from adult mouse liver and stomach cells","volume":"321","author":"Aoi","year":"2008","journal-title":"Science"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/stem.1293","article-title":"An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells","volume":"31","author":"Okita","year":"2013","journal-title":"Stem Cells"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature09342","article-title":"Epigenetic memory in induced pluripotent stem cells","volume":"467","author":"Kim","year":"2010","journal-title":"Nature"},{"key":"ref_55","first-page":"43","article-title":"Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs)","volume":"10","author":"Singh","year":"2015","journal-title":"J. Stem Cells"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nbt.1529","article-title":"Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling","volume":"27","author":"Chambers","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s12015-021-10254-3","article-title":"Human iPSC-Derived Neural Models for Studying Alzheimer\u2019s Disease: From Neural Stem Cells to Cerebral Organoids","volume":"18","author":"Barak","year":"2022","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1101\/gad.1616208","article-title":"Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage","volume":"22","author":"Elkabetz","year":"2008","journal-title":"Genes Dev."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1073\/pnas.0808387106","article-title":"A rosette-type, self-renewing human ES cell-derived neural stem cell with potential for in vitro instruction and synaptic integration","volume":"106","author":"Koch","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/nbt1201-1129","article-title":"In vitro differentiation of transplantable neural precursors from human embryonic stem cells","volume":"19","author":"Zhang","year":"2001","journal-title":"Nat. Biotechnol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature10202","article-title":"Induction of human neuronal cells by defined transcription factors","volume":"476","author":"Pang","year":"2011","journal-title":"Nature"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuron.2013.05.029","article-title":"Rapid Single-Step Induction of Functional Neurons from Human Pluripotent Stem Cells","volume":"78","author":"Zhang","year":"2013","journal-title":"Neuron"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Flitsch, L.J., Laupman, K.E., and Br\u00fcstle, O. (2020). Transcription Factor-Based Fate Specification and Forward Programming for Neural Regeneration. Front. Cell. Neurosci., 14.","DOI":"10.3389\/fncel.2020.00121"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e18648","DOI":"10.7554\/eLife.18648","article-title":"Maintenance of age in human neurons generated by microRNA-based neuronal conversion of fibroblasts","volume":"5","author":"Huh","year":"2001","journal-title":"eLife"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nature10323","article-title":"MicroRNA-mediated conversion of human fibroblasts to neurons","volume":"476","author":"Yoo","year":"2011","journal-title":"Nature"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.stem.2015.09.001","article-title":"Directly Reprogrammed Human Neurons Retain Aging-Associated Transcriptomic Signatures and Reveal Age-Related Nucleocytoplasmic Defects","volume":"17","author":"Mertens","year":"2015","journal-title":"Cell Stem Cell"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00441-020-03287-6","article-title":"GDNF synthesis, signaling, and retrograde transport in motor neurons","volume":"382","author":"Boynton","year":"2020","journal-title":"Cell Tissue Res."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Lepski, G.P., Jannes, C.E., Nikkhah, G., and Bischofberger, J. (2013). cAMP promotes the differentiation of neural progenitor cells in vitro via modulation of voltage-gated calcium channels. Front. Cell. Neurosci., 7.","DOI":"10.3389\/fncel.2013.00155"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Jang, S., Cho, H.H., Cho, Y.B., Park, J.S., and Jeong, H.S. (2010). Functional neural differentiation of human adipose tissue-derived stem cells using bFGF and forskolin. BMC Cell Biol., 11.","DOI":"10.1186\/1471-2121-11-25"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s00018-014-1815-9","article-title":"Retinoic acid signaling and neuronal differentiation","volume":"72","author":"Janesick","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Busskamp, V., Lewis, N.E., Guye, P., Ng, A.H., Shipman, S.L., Byrne, S.M., Sanjana, N.E., Murn, J., Li, Y., and Li, S. (2014). Rapid neurogenesis through transcriptional activation in human stem cells. Mol. Syst. Biol., 10.","DOI":"10.15252\/msb.20145508"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.stemcr.2014.12.002","article-title":"Direct conversion of fibroblasts into functional astrocytes by defined transcription factors","volume":"4","author":"Caiazzo","year":"2015","journal-title":"Stem Cell Rep."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.stem.2011.09.002","article-title":"Direct Lineage Conversion of Terminally Differentiated Hepatocytes to Functional Neurons","volume":"9","author":"Marro","year":"2011","journal-title":"Cell Stem Cell"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.stem.2011.07.002","article-title":"Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions","volume":"9","author":"Ambasudhan","year":"2011","journal-title":"Cell Stem Cell"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"7828049","DOI":"10.1155\/2016\/7828049","article-title":"Modeling Alzheimer\u2019s Disease with Induced Pluripotent Stem Cells: Current Challenges and Future Concerns","volume":"2016","author":"Zhang","year":"2016","journal-title":"Stem Cells Int."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.stemcr.2017.06.018","article-title":"An Efficient Platform for Astrocyte Differentiation from Human Induced Pluripotent Stem Cells","volume":"9","author":"Tcw","year":"2017","journal-title":"Stem Cell Rep."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"134681","DOI":"10.1016\/j.neulet.2019.134681","article-title":"Rapid differentiation of astrocytes from human embryonic stem cells","volume":"716","author":"Byun","year":"2020","journal-title":"Neurosci. Lett."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Ren, B., and Dunaevsky, A. (2021). Modeling Neurodevelopmental and Neuropsychiatric Diseases with Astrocytes Derived from Human-Induced Pluripotent Stem Cells. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041692"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41592-018-0103-2","article-title":"Rapid and efficient induction of functional astrocytes from human pluripotent stem cells","volume":"15","author":"Canals","year":"2018","journal-title":"Nat. Methods"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41587-019-0035-0","article-title":"NFIA is a gliogenic switch enabling rapid derivation of functional human astrocytes from pluripotent stem cells","volume":"37","author":"Tchieu","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-1-4939-9477-9_3","article-title":"Generating Human iPSC-Derived Astrocytes with Chemically Defined Medium for In vitro Disease Modeling","volume":"Volume 1994","author":"Mandenius","year":"2019","journal-title":"Cell-Based Assays Using iPSCs for Drug Development and Testing"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1021\/acsbiomaterials.0c00067","article-title":"A Defined and Scalable Peptide-Based Platform for the Generation of Human Pluripotent Stem Cell-Derived Astrocytes","volume":"6","author":"Raman","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.neuron.2011.07.022","article-title":"Development of a method for the purification and culture of rodent astrocytes","volume":"71","author":"Foo","year":"2011","journal-title":"Neuron"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1126\/science.1226740","article-title":"Glutamate-dependent neuroglial calcium signaling differs between young and adult brain","volume":"399","author":"Sun","year":"2013","journal-title":"Science"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.neuron.2017.03.042","article-title":"iPSC-Derived Human Microglia-like Cells to Study Neurological Diseases","volume":"94","author":"Abud","year":"2017","journal-title":"Neuron"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Nagy, A., and Turksen, K. (2021). Human Pluripotent Stem Cell Differentiation to Microglia. Induced Pluripotent Stem (iPS) Cells, Humana.","DOI":"10.1007\/978-1-0716-2119-6"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13024-018-0297-x","article-title":"Development and validation of a simplified method to generate human microglia from pluripotent stem cells","volume":"13","author":"McQuade","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/nm.4189","article-title":"Efficient derivation of microglia- like cells from human pluripotent stem cells","volume":"22","author":"Muffat","year":"2016","journal-title":"Nat. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13024-019-0347-z","article-title":"Generating microglia from human pluripotent stem cells: Novel in vitro models for the study of neurodegeneration","volume":"14","author":"Speicher","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41467-022-28043-y","article-title":"Expression of the transcription factor, P.U.1 induces the generation of microglia-like cells in human cortical organoids","volume":"13","author":"Cakir","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nn.3318","article-title":"Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways","volume":"16","author":"Kierdorf","year":"2013","journal-title":"Nat. Neurosci."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nn.4534","article-title":"Differentiation of human and murine induced pluripotent stem cells to microglia-like cells","volume":"20","author":"Pandya","year":"2017","journal-title":"Nat. Neurosci."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Kuhn, S., Gritti, L., Crooks, D., and Dombrowski, Y. (2019). Oligodendrocytes in Development, Myelin Generation and Beyond. Cells, 8.","DOI":"10.3390\/cells8111424"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1242\/dev.126409","article-title":"How to make an oligodendrocyte","volume":"142","author":"Goldman","year":"2015","journal-title":"Development"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"8467","DOI":"10.1523\/JNEUROSCI.0311-14.2014","article-title":"Stage-Specific Regulation of Oligodendrocyte Development by Wnt\/\u03b2-Catenin Signaling","volume":"34","author":"Dai","year":"2014","journal-title":"J. Neurosci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/nprot.2015.075","article-title":"Generation and isolation of oligodendrocyte progenitor cells from human pluripotent stem cells","volume":"10","author":"Douvaras","year":"2015","journal-title":"Nat. Protoc."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Shi, B., Ding, J., Liu, Y., Zhuang, X., Zhuang, X., Chen, X., and Fu, C. (2014). ERK1\/2 pathway-mediated differentiation of IGF- 1-transfected spinal cord-derived neural stem Cells into oligodendrocytes. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0106038"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"E2243","DOI":"10.1073\/pnas.1614412114","article-title":"Rapid and efficient generation of oligodendrocytes from human induced pluripotent stem cells using transcription factors","volume":"114","author":"Ehrlich","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.stemcr.2021.03.001","article-title":"One-step Reprogramming of Human Fibroblasts into Oligodendrocyte-like Cells by SOX10, OLIG2, and NKX6.2","volume":"16","author":"Chanoumidou","year":"2021","journal-title":"Stem Cell Rep."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41592-018-0081-4","article-title":"Induction of myelinating oligodendrocytes in human cortical spheroids","volume":"15","author":"Madhavan","year":"2018","journal-title":"Nat. Methods"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41586-018-0360-3","article-title":"Accumulation of 8, 9-unsaturated sterols drives oligodendrocyte formation and remyelination","volume":"560","author":"Hubler","year":"2018","journal-title":"Nature"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Lyons, D., and Kegel, L. (2019). Oligodendrocyte-Neuron Myelinating Coculture. Oligodendrocytes, Humana Press.","DOI":"10.1007\/978-1-4939-9072-6"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/nbt.1972","article-title":"CD140a identifies a population of highly myelinogenic, migration-competent and efficiently engrafting human oligodendrocyte progenitor cells","volume":"29","author":"Sim","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Abe-Fukasawa, N., Otsuka, K., Aihara, A., Itasaki, N., and Nishino, T. (2018). Novel 3D Liquid Cell Culture Method for Anchorage-independent Cell Growth, Cell Imaging and Automated Drug Screening. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-21950-5"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature12517","article-title":"Cerebral organoids model human brain development and microcephaly","volume":"501","author":"Lancaster","year":"2013","journal-title":"Nature"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ydbio.2016.06.037","article-title":"Dishing out mini-brains: Current progress and future prospects in brain organoid research","volume":"420","author":"Kelava","year":"2016","journal-title":"Dev. Biol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1007\/s12015-024-10776-6","article-title":"Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs)","volume":"20","author":"Manganelli","year":"2024","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1016\/j.cell.2022.06.051","article-title":"Human organoids: New strategies and methods for analyzing human development and disease","volume":"185","author":"Corsini","year":"2022","journal-title":"Cell"},{"key":"ref_109","first-page":"617","article-title":"Past, Present, and Future of Brain Organoid Technology","volume":"42","author":"Koo","year":"2019","journal-title":"Mol. Cells"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ncb3312","article-title":"Organoids as an in vitro model of human development and disease","volume":"18","author":"Fatehullah","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41580-020-0259-3","article-title":"Human organoids: Model systems for human biology and medicine","volume":"21","author":"Kim","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev-pathmechdis-012419-032611","article-title":"Human organoids: Tools for understanding biology and treating diseases","volume":"15","author":"Schutgens","year":"2020","journal-title":"Annu. Rev. Pathol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41578-021-00279-y","article-title":"Engineering organoids","volume":"6","author":"Hofer","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41576-018-0051-9","article-title":"Progress and potential in organoid research","volume":"19","author":"Rossi","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Kyrousi, C., and Cappello, S. (2020). Using brain organoids to study human neurodevelopment, evolution and disease. Wiley Interdiscip. Rev. Dev. Biol., 9.","DOI":"10.1002\/wdev.347"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1247125","DOI":"10.1126\/science.1247125","article-title":"Organogenesis in a dish: Modeling development and disease using organoid technologies","volume":"345","author":"Lancaster","year":"2014","journal-title":"Science"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/s41587-019-0085-3","article-title":"Specification of positional identity in forebrain organoids","volume":"37","author":"Cederquist","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.stem.2020.02.002","article-title":"Sliced human cortical organoids for modeling distinct cortical layer formation","volume":"26","author":"Qian","year":"2020","journal-title":"Cell Stem Cell"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Abbott, J., Tambe, M., Pavlinov, I., Farkhondeh, A., Nguyen, H.N., Xu, M., Pradhan, M., York, T., Might, M., and Baumg\u00e4rtel, K. (2023). Generation and characterization of NGLY1 patient-derived midbrain organoids. Front. Cell Dev. Biol., 11.","DOI":"10.3389\/fcell.2023.1039182"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/glia.24167","article-title":"Microglia integration into human midbrain organoids leads to increased neuronal maturation and functionality","volume":"70","author":"Nickels","year":"2022","journal-title":"Glia"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.stem.2016.07.005","article-title":"Midbrain-like Organoids from Human Pluripotent Stem Cells Contain Functional Dopaminergic and Neuromelanin-Producing Neurons","volume":"19","author":"Jo","year":"2016","journal-title":"Cell Stem Cell"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"102413","DOI":"10.1016\/j.xpro.2023.102413","article-title":"Generation of mouse hippocampal brain organoids from primary embryonic neural stem cells","volume":"4","author":"Ciarpella","year":"2023","journal-title":"STAR Protoc."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.stem.2018.04.009","article-title":"Efficient Generation of CA3 Neurons from Human Pluripotent Stem Cells Enables Modeling of Hippocampal Connectivity In Vitro","volume":"22","author":"Sarkar","year":"2018","journal-title":"Cell Stem Cell"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"8896","DOI":"10.1038\/ncomms9896","article-title":"Generation of functional hippocampal neurons from self-organizing human embryonic stem cell-derived dorsomedial telencephalic tissue","volume":"6","author":"Sakaguchi","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.stem.2012.05.009","article-title":"Self-formation of optic cups and storable stratified neural retina from human ESCs","volume":"10","author":"Nakano","year":"2012","journal-title":"Cell Stem Cell"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.stem.2024.09.017","article-title":"Assembloid models of cell-cell interaction to study tissue and disease biology","volume":"31","author":"Onesto","year":"2024","journal-title":"Cell Stem Cell"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nbt.2052","article-title":"Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells","volume":"29","author":"Kim","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Hossini, A.M., Megges, M., Prigione, A., Lichtner, B., Toliat, M.R., Wruck, W., Schr\u00f6ter, F., Nuernberg, P., Kroll, H., and Makrantonaki, E. (2015). Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer\u2019s disease donor as a model for investigating AD-associated gene regulatory networks. BMC Genom., 16.","DOI":"10.1186\/s12864-015-1537-x"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.stem.2015.02.004","article-title":"Elucidating molecular phenotypes caused by the SORL1 Alzheimer\u2019s disease genetic risk factor using human induced pluripotent stem cells","volume":"16","author":"Young","year":"2015","journal-title":"Cell Stem Cell"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"107719","DOI":"10.1016\/j.celrep.2020.107719","article-title":"Depletion of the AD Risk Gene SORL1 Selectively Impairs Neuronal Endosomal Traffic Independent of Amyloidogenic APP Processing","volume":"31","author":"Knupp","year":"2020","journal-title":"Cell Rep."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1016\/j.ajpath.2012.02.012","article-title":"Presenilin-1 L166P mutant human pluripotent stem cell\u2013derived neurons exhibit partial loss of \u03b3-secretase activity in endogenous Amyloid-\u03b2 generation","volume":"180","author":"Koch","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1093\/hmg\/ddr394","article-title":"Modeling familial Alzheimer\u2019s disease with induced pluripotent stem cells","volume":"20","author":"Yagi","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.celrep.2015.03.068","article-title":"APP metabolism regulates tau proteostasis in human cerebral cortex neurons","volume":"11","author":"Moore","year":"2015","journal-title":"Cell Rep."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.celrep.2018.04.040","article-title":"Extracellular Forms of A\u03b2 and Tau from iPSC Models of Alzheimer\u2019s Disease Disrupt Synaptic Plasticity","volume":"23","author":"Hu","year":"2018","journal-title":"Cell Rep."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature10821","article-title":"Probing sporadic and familial Alzheimer\u2019s disease using induced pluripotent stem cells","volume":"482","author":"Israel","year":"2012","journal-title":"Nature"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1038\/s41467-020-19264-0","article-title":"APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer\u2019s disease patient iPSC-derived cerebral organoids","volume":"11","author":"Zhao","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.scr.2018.01.019","article-title":"Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-\u03b2 and tau pathology in iPSC-derived neurons from sporadic Alzheimer\u2019s disease patients","volume":"27","author":"Birnbaum","year":"2018","journal-title":"Stem Cell Res."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"103631","DOI":"10.1016\/j.mcn.2021.103631","article-title":"Amyloid-\u03b2 Precursor Protein Processing and Oxidative Stress are Altered in Human iPSC-Derived Neuron and Astrocyte Co-Cultures Carrying Pre- senillin-1 Gene Mutations Following Spontaneous Differentiation","volume":"114","author":"Elsworthy","year":"2021","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neulet.2016.12.060","article-title":"Increased susceptibility to A\u03b2 toxicity in neuronal cultures derived from familial Alzheimer\u2019s disease (PSEN1-A246E) induced pluripotent stem cells","volume":"639","author":"Armijo","year":"2017","journal-title":"Neurosci. Lett."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13195-017-0317-z","article-title":"Neurons derived from sporadic Alzheimer\u2019s disease iPSCs reveal elevated TAU hyper-phosphorylation, increased amyloid levels, and GSK3B activation","volume":"9","author":"Ochalek","year":"2017","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.celrep.2019.01.023","article-title":"REST and Neural Gene Network Dysregulation in iPSC Models of Alzheimer\u2019s Disease","volume":"26","author":"Meyer","year":"2019","journal-title":"Cell Rep."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"7900","DOI":"10.18632\/oncotarget.13776","article-title":"Early pathogenic event of Alzheimer\u2019s disease documented in iPSCs from patients with PSEN1 mutations","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","article-title":"APOE4 causes widespread molecular and cellular alterations associated with Alzheimer\u2019s disease phenotypes in human iPSC-derived brain cell types","volume":"98","author":"Lin","year":"2018","journal-title":"Neuron"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jalz.2018.09.006","article-title":"Human stem cell\u2013derived monocytes and microglia-like cells reveal impaired amyloid plaque clearance upon heterozygous or homozygous loss of TREM2","volume":"15","author":"Claes","year":"2019","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.stemcr.2017.10.016","article-title":"PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer\u2019s Disease","volume":"9","author":"Oksanen","year":"2017","journal-title":"Stem Cell Rep."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"e2696","DOI":"10.1038\/cddis.2017.89","article-title":"Aberrant iPSC-derived human astrocytes in Alzheimer\u2019s disease","volume":"8","author":"Jones","year":"2017","journal-title":"Cell Death Dis."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"11341","DOI":"10.1074\/jbc.RA117.000441","article-title":"Full-length amyloid precursor protein regulates lipoprotein metabolism and amyloid-\u03b2 clearance in human astrocytes","volume":"293","author":"Fong","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"eaaz4564","DOI":"10.1126\/scitranslmed.aaz4564","article-title":"APOE4 disrupts intracellular lipid homeostasis in human iPSC-derived glia","volume":"13","author":"Sienski","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40035-023-00385-7","article-title":"Oligodendrocyte progenitor cells in Alzheimer\u2019s disease: From physiology to pathology","volume":"12","author":"Zou","year":"2003","journal-title":"Transl. Neurodegener."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nature13800","article-title":"A three-dimensional human neural cell culture model of Alzheimer\u2019s disease","volume":"515","author":"Choi","year":"2014","journal-title":"Nature"},{"key":"ref_151","first-page":"5766","article-title":"Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain","volume":"26","author":"Goh","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1038\/s41380-018-0229-8","article-title":"Modeling amyloid beta and tau pathology in human cerebral organoids","volume":"23","author":"Gonzalez","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Pavoni, S., Jarray, R., Nassor, F., Guyot, A.C., Cottin, S., Rontard, J., Mikol, J., Mabondzo, A., Deslys, J.P., and Yates, F. (2018). Small-molecule induction of A\u03b2-42 peptide production in human cerebral organoids to model Alzheimer\u2019s disease associated phenotypes. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0209150"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Raja, W.K., Mungenast, A.E., Lin, Y.T., Ko, T., Abdurrob, F., Seo, J., and Tsai, L.H. (2016). Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer\u2019s Disease Phenotypes. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0161969"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41467-020-20440-5","article-title":"A logical network-based drug-screening platform for Alzheimer\u2019s disease representing pathological features of human brain organoids","volume":"12","author":"Park","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Ye, T., Duan, Y., Tsang, H.W.S., Xu, H., Chen, Y., Cao, H., Chen, Y., Fu, A.K.Y., and Ip, N.Y. (2021). Efficient manipulation of gene dosage in human iPSCs using CRISPR\/Cas9 nickases. Commun. Biol., 4.","DOI":"10.1038\/s42003-021-01722-0"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","article-title":"Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a smallmolecule structure corrector","volume":"24","author":"Wang","year":"2018","journal-title":"Nat. Med."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13024-021-00473-0","article-title":"Plaque-associated human microglia accumulate lipid droplets in a chimeric model of Alzheimer\u2019s disease","volume":"16","author":"Claes","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.tins.2022.05.001","article-title":"Induced pluripotent stem cells: A tool for modeling Parkinson\u2019s disease","volume":"45","author":"Bose","year":"2022","journal-title":"Trends Neurosci."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"e350","DOI":"10.1038\/cddis.2012.94","article-title":"Alpha-synuclein: From secretion to dysfunction and death","volume":"3","author":"Marques","year":"2012","journal-title":"Cell Death Dis."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3390\/jcm4040548","article-title":"Using iPS Cells toward the Understanding of Parkinson\u2019s Disease","volume":"4","author":"Torrent","year":"2015","journal-title":"J. Clin. Med."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.stem.2015.01.018","article-title":"Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson\u2019s disease","volume":"16","author":"Hallett","year":"2015","journal-title":"Cell Stem Cell"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ncomms1453","article-title":"Parkinson\u2019s disease induced pluripotent stem cells with triplication of the alpha-synuclein locus","volume":"2","author":"Devine","year":"2011","journal-title":"Nat. Commun."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Byers, B., Cord, B., Nguyen, H.N., Sch\u00fcle, B., Fenno, L., Lee, P.C., Deisseroth, K., Langston, J.W., Pera, R.R., and Palmer, T.D. (2011). SNCA triplication Parkinson\u2019s patient\u2019s iPSC-derived DA neurons accumulate alpha-synuclein and are susceptible to oxidative stress. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0026159"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1093\/hmg\/ddx331","article-title":"Alpha-synuclein induces the unfolded protein response in Parkinson\u2019s disease SNCA triplication iPSC-derived neurons","volume":"26","author":"Manzano","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"7813","DOI":"10.1073\/pnas.1713129115","article-title":"Alpha-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies","volume":"115","author":"Prots","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1038\/s41467-018-04422-2","article-title":"Alpha-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson\u2019s disease","volume":"9","author":"Ludtmann","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1126\/science.1245296","article-title":"Identification and rescue of alpha-synuclein toxicity in Parkinson patient-derived neurons","volume":"342","author":"Chung","year":"2013","journal-title":"Science"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/hmg\/ddz038","article-title":"Cellular alpha-synuclein pathology is associated with bioenergetic dysfunction in Parkinson\u2019s iPSC-derived dopamine neurons","volume":"28","author":"Zambon","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"E3679","DOI":"10.1073\/pnas.1617259114","article-title":"Defective synaptic connectivity and axonal neuropathology in a human iPSC-based model of familial Parkinson\u2019s disease","volume":"114","author":"Kouroupi","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.cell.2013.11.009","article-title":"Isogenic human iPSC Parkinson\u2019s model shows nitrosative stress-induced dysfunction in MEF2-PGC1 transcription","volume":"155","author":"Ryan","year":"2013","journal-title":"Cell"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nrn2935","article-title":"The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson\u2019s disease","volume":"11","author":"Cookson","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/mds.28346","article-title":"Upregulation of Cellular Palmitoylation Mitigates alpha-Synuclein Accumulation and Neurotoxicity","volume":"36","author":"Ho","year":"2021","journal-title":"Mov. Disord."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.stem.2011.01.013","article-title":"LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress","volume":"8","author":"Nguyen","year":"2011","journal-title":"Cell Stem Cell"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/emmm.201200215","article-title":"Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson\u2019s disease","volume":"4","author":"Caig","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.stem.2013.01.008","article-title":"Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression","volume":"12","author":"Reinhardt","year":"2013","journal-title":"Cell Stem Cell"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nn.3350","article-title":"Interplay of LRRK2 with chaperone-mediated autophagy","volume":"16","author":"Orenstein","year":"2013","journal-title":"Nat. Neurosci."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrn3156","article-title":"Mitochondrial transport in neurons: Impact on synaptic homeostasis and neurodegeneration","volume":"13","author":"Sheng","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neurobiolaging.2020.12.001","article-title":"Impaired dopamine D3 and nicotinic acetylcholine receptor membrane localization in iPSCs-derived dopaminergic neurons from two Parkinson\u2019s disease patients carrying the LRRK2 G2019S mutation","volume":"99","author":"Bono","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/mds.23469","article-title":"The motor phenotype of Parkinson\u2019s disease in relation to age at onset","volume":"26","author":"Wickremaratchi","year":"2011","journal-title":"Mov. Disord."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"5","author":"Breteler","year":"2006","journal-title":"Lancet Neurol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ncomms1669","article-title":"Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells","volume":"3","author":"Jiang","year":"2012","journal-title":"Nat. Commun."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1756-6606-5-35","article-title":"Mitochondrial dysfunction associated with increased oxidative stress and alpha-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue","volume":"5","author":"Imaizumi","year":"2012","journal-title":"Mol. Brain"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.stemcr.2016.08.012","article-title":"Parkin and PINK1 Patient iPSC-Derived Midbrain Dopamine Neurons Exhibit Mitochondrial Dysfunction and alpha-Synuclein Accumulation","volume":"7","author":"Chung","year":"2016","journal-title":"Stem Cell Rep."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.celrep.2017.10.068","article-title":"S-Nitrosylation of PINK1 Attenuates PINK1\/Parkin-Dependent Mitophagy in hiPSC-Based Parkinson\u2019s Disease Models","volume":"21","author":"Oh","year":"2017","journal-title":"Cell Rep."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"141ra190","DOI":"10.1126\/scitranslmed.3003985","article-title":"Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson\u2019s disease","volume":"4","author":"Cooper","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"152","DOI":"10.5966\/sctm.2015-0059","article-title":"Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog","volume":"5","author":"Ohuchi","year":"2016","journal-title":"Stem Cells Transl. Med."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/1087057115588287","article-title":"High-Throughput Screening Using iPSC-Derived Neuronal Progenitors to Identify Compounds Counteracting Epigenetic Gene Silencing in Fragile X Syndrome","volume":"20","author":"Kaufmann","year":"2015","journal-title":"J. Biomol. Screen."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.stemcr.2018.12.011","article-title":"Patient-specific iPSC-Derived astrocytes contribute to non-cell-autonomous neurodegeneration in Parkinson\u2019s disease","volume":"12","author":"Carola","year":"2019","journal-title":"Stem Cell Rep."},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Mamais, A., Kluss, J.H., Bonet-Ponce, L., Landeck, N., Langston, R.G., Smith, N., Beilina, A., Kaganovich, A., Ghosh, M.C., and Pellegrini, L. (2021). Mutations in LRRK2 linked to Parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia. PLoS Biol., 19, Erratum in PLoS Biol. 2022, 20, e3001621.","DOI":"10.1371\/journal.pbio.3001621"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41531-021-00175-w","article-title":"Astrocytic atrophy as a pathological feature of Parkinson\u2019s disease with LRRK2 mutation","volume":"7","author":"Mato","year":"2021","journal-title":"NPJ Park. Dis."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1038\/s41467-020-18755-4","article-title":"Interferon-gamma signaling synergizes with LRRK2 in neurons and microglia derived from human induced pluripotent stem cells","volume":"11","author":"Panagiotakopoulou","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Haenseler, W., Zambon, F., Lee, H., Vowles, J., Rinaldi, F., Duggal, G., Houlden, H., Gwinn, K., Wray, S., and Luk, K.C. (2017). Excess alpha-synuclein compromises phagocytosis in iPSC-derived macrophages. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-09362-3"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11557","article-title":"Progressive degeneration of human neural stem cells caused by pathogenic LRRK2","volume":"491","author":"Liu","year":"2012","journal-title":"Nature"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neurobiolaging.2018.05.032","article-title":"MicroRNA alterations in iPSC-derived dopaminergic neurons from Parkinson disease patients","volume":"69","author":"Tolosa","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1800927","DOI":"10.1002\/advs.201800927","article-title":"3D Cultures of Parkinson\u2019s Disease-Specific Dopaminergic Neurons for High Content Phenotyping and Drug Testing","volume":"6","author":"Bolognin","year":"2019","journal-title":"Adv. Sci."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41531-019-0078-4","article-title":"Modeling Parkinson\u2019s disease in midbrain-like organoids","volume":"5","author":"Smits","year":"2019","journal-title":"NPJ Park. Dis."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nature17939","article-title":"Parkinson-associated risk variant in distal enhancer of \u03b1-synuclein modulates target gene expression","volume":"533","author":"Soldner","year":"2016","journal-title":"Nature"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.scr.2017.08.013","article-title":"CRISPR\/Cas9 and piggyBacmediated footprint-free LRRK2-G2019S knock-in reveals neuronal complexity phenotypes and \u03b1-Synuclein modulation in dopaminergic neurons","volume":"24","author":"Qing","year":"2017","journal-title":"Stem Cell Res."},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Sonninen, T.-M., H\u00e4m\u00e4l\u00e4inen, R.H., Koskuvi, M., Oksanen, M., Shakirzyanova, A., Wojciechowski, S., Puttonen, K., Naumenko, N., Goldsteins, G., and Laham-Karam, N. (2020). Metabolic alterations in Parkinson\u2019s disease astrocytes. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-71329-8"},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Hanss, Z., Boussaad, I., Jarazo, J., Schwamborn, J.C., and Kruger, R. (2020). Quality control strategy for CRISPR-Cas9-based gene editing complicated by a pseudogene. Front. Genet., 10.","DOI":"10.3389\/fgene.2019.01297"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.stemcr.2019.12.005","article-title":"Pathogenic pathways in early-onset autosomal recessive Parkinson\u2019s disease discovered using isogenic human dopaminergic neurons","volume":"14","author":"Ahfeldt","year":"2020","journal-title":"Stem Cell Rep."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"102806","DOI":"10.1016\/j.scr.2022.102806","article-title":"Generation of homozygous PRKN, PINK1 and double PINK1\/PRKN knockout cell lines from healthy induced pluripotent stem cells using CRISPR\/Cas9 editing","volume":"62","author":"Chen","year":"2022","journal-title":"Stem Cell Res."},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Harjuhaahto, S., Rasila, T.S., Molchanova, S.M., Woldegebriel, R., Kvist, J., Konovalova, S., Sainio, M.T., Pennonen, J., Torregrosa-Mu\u00f1umer, R., and Ibrahim, H. (2020). ALS and Parkinson\u2019s disease genes CHCHD10 and CHCHD2 modify synaptic transcriptomes in human iPSC-derived motor neurons. Neurobiol. Dis., 141.","DOI":"10.1016\/j.nbd.2020.104940"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: Natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"HD iPSC Consortium (2012). Induced pluripotent stem cells from patients with Huntington\u2019s disease show CAG-repeat-expansion-associated phenotypes. Cell Stem Cell, 11, 264\u2013278.","DOI":"10.1016\/j.stem.2012.04.027"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1756-6606-5-17","article-title":"Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington\u2019s disease patient cells","volume":"5","author":"Juopperi","year":"2012","journal-title":"Mol. Brain"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1093\/hmg\/ddv080","article-title":"HD iPSC-derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicity","volume":"24","author":"Mattis","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13024-016-0092-5","article-title":"Manifestation of Huntington\u2019s disease pathology in human induced pluripotent stem cell-derived neurons","volume":"11","author":"Nekrasov","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.stem.2012.04.026","article-title":"Genetic correction of Huntington\u2019s disease phenotypes in induced pluripotent stem cells","volume":"11","author":"An","year":"2012","journal-title":"Cell Stem Cell"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1002\/stem.1135","article-title":"Neuronal properties, in vivo effects, and pathology of a Huntington\u2019s disease patient-derived induced pluripotent stem cells","volume":"30","author":"Jeon","year":"2012","journal-title":"Stem Cells"},{"key":"ref_212","doi-asserted-by":"crossref","unstructured":"Zhang, N., An, M.C., Montoro, D., and Ellerby, L.M. (2010). Characterization of human Huntington\u2019s disease cell model from induced pluripotent stem cells. PLoS Curr., 2.","DOI":"10.1371\/currents.RRN1193"},{"key":"ref_213","doi-asserted-by":"crossref","unstructured":"Oura, S., Noda, T., Morimura, N., Hitoshi, S., Nishimasu, H., Nagai, Y., Nureki, O., and Ikawa, M. (2021). Precise CAG repeat contraction in a Huntington\u2019s disease mouse model is enabled by gene editing with SpCas9-NG. Commun. Biol., 4.","DOI":"10.1038\/s42003-021-02304-w"},{"key":"ref_214","first-page":"4566","article-title":"Permanent inactivation of Huntington\u2019s disease mutation by personalized allele-specific CRISPR\/Cas9","volume":"25","author":"Shin","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.celrep.2016.10.026","article-title":"Vulnerability of Purkinje cells generated from spinocerebellar ataxia type 6 patient-derived iPSCs","volume":"17","author":"Ishida","year":"2016","journal-title":"Cell Rep."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature10671","article-title":"Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease","volume":"480","author":"Koch","year":"2011","journal-title":"Nature"},{"key":"ref_217","doi-asserted-by":"crossref","unstructured":"Ou, Z., Luo, M., Niu, X., Chen, Y., Xie, Y., He, W., Song, B., Xian, Y., Fan, D., and OuYang, S. (2016). Autophagy Promoted the degradation of mutant ATXN3 in neurally differentiated spinocerebellar Ataxia-3 Human induced pluripotent stem cells. Biomed. Res. Int., 2016.","DOI":"10.1155\/2016\/6701793"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature07677","article-title":"Induced pluripotent stem cells from a spinal muscular atrophy patient","volume":"457","author":"Ebert","year":"2009","journal-title":"Nature"},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Fuller, H.R., Mandefro, B., Shirran, S.L., Gross, A.R., Kaus, A.S., Botting, C.H., Morris, G.E., and Sareen, D. (2015). Spinal Muscular atrophy patient iPSC-Derived motor neurons have reduced expression of proteins important in neuronal development. Front. Cell. Neurosci., 9.","DOI":"10.3389\/fncel.2015.00506"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"42030","DOI":"10.18632\/oncotarget.14925","article-title":"Modeling the differential phenotypes of spinal muscular atrophy with high-yield generation of motor neurons from human induced pluripotent stem cells","volume":"8","author":"Lin","year":"2017","journal-title":"Oncotarget"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.stemcr.2015.02.010","article-title":"Modeling the early phenotype at the neuromuscular junction of spinal muscular atrophy using patient-derived iPSCs","volume":"4","author":"Yoshida","year":"2015","journal-title":"Stem Cell Rep."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/glia.22522","article-title":"Spinal muscular atrophy astrocytes exhibit abnormal calcium regulation and reduced growth factor production","volume":"61","author":"McGivern","year":"2013","journal-title":"Glia"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s40478-016-0337-0","article-title":"Modeling Alexander disease with patient iPSCs reveals cellular and molecular pathology of astrocytes","volume":"4","author":"Kondo","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.stem.2018.07.009","article-title":"GFAP Mutations in astrocytes impair oligodendrocyte progenitor proliferation and myelination in an hiPSC model of alexander disease","volume":"23","author":"Li","year":"2018","journal-title":"Cell Stem Cell"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/8\/3774\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:15:55Z","timestamp":1760030155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/8\/3774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":224,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["ijms26083774"],"URL":"https:\/\/doi.org\/10.3390\/ijms26083774","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,16]]}}}